These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7756638)
1. Involvement of the cysteine-rich domain of glycoprotein IIIa in the expression of the human platelet alloantigen, PlA1: evidence for heterogeneity in the humoral response. Valentin N; Visentin GP; Newman PJ Blood; 1995 Jun; 85(11):3028-33. PubMed ID: 7756638 [TBL] [Abstract][Full Text] [Related]
2. Localization of a PlA1 epitope to the amino terminal 66 residues of platelet glycoprotein IIIa. Bowditch RD; Tani PH; Halloran CE; Frelinger AL; McMillan R; Ginsberg MH Blood; 1992 Feb; 79(3):559-62. PubMed ID: 1370635 [TBL] [Abstract][Full Text] [Related]
3. A 13-mer peptide straddling the leucine33/proline33 polymorphism in glycoprotein IIIa does not define the PLA1 epitope. Flug F; Espinola R; Liu LX; SinQuee C; DaRosso R; Nardi M; Karpatkin S Blood; 1991 May; 77(9):1964-9. PubMed ID: 1708295 [TBL] [Abstract][Full Text] [Related]
4. An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system. Wang R; Furihata K; McFarland JG; Friedman K; Aster RH; Newman PJ J Clin Invest; 1992 Nov; 90(5):2038-43. PubMed ID: 1430225 [TBL] [Abstract][Full Text] [Related]
5. Development of a monoclonal antibody capable of differentiating platelet PLA1/PLA1, PLA1/PLA2 and PLA2/PLA2 genotypes. Liu LX; Nardi M; Flug F; Karpatkin S Br J Haematol; 1992 May; 81(1):113-7. PubMed ID: 1520609 [TBL] [Abstract][Full Text] [Related]
6. Competitive binding of a monoclonal antibody SZ-21 with anti-PLA1 antibodies and its potential for clinical application. Xi X; Zhao Y; Jiang H; Wu Q; Li P; Ruan C Nouv Rev Fr Hematol (1978); 1992; 34(3):239-42. PubMed ID: 1383923 [TBL] [Abstract][Full Text] [Related]
7. On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. Furihata K; Nugent DJ; Bissonette A; Aster RH; Kunicki TJ J Clin Invest; 1987 Dec; 80(6):1624-30. PubMed ID: 2445781 [TBL] [Abstract][Full Text] [Related]
8. A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta(3) integrin: the Oe(a) alloantigen in neonatal alloimmune thrombocytopenia. Santoso S; Kiefel V; Richter IG; Sachs UJ; Rahman A; Carl B; Kroll H Blood; 2002 Feb; 99(4):1205-14. PubMed ID: 11830467 [TBL] [Abstract][Full Text] [Related]
9. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. Newman PJ; Derbes RS; Aster RH J Clin Invest; 1989 May; 83(5):1778-81. PubMed ID: 2565345 [TBL] [Abstract][Full Text] [Related]
10. Construction of a human platelet alloantigen-1a epitope(s) within murine glycoprotein IIIa: identification of residues critical to the conformation of the antibody binding site(s). Barron-Casella EA; Nebbia G; Rogers OC; King KE; Kickler TS; Casella JF Blood; 1999 May; 93(9):2959-67. PubMed ID: 10216091 [TBL] [Abstract][Full Text] [Related]
11. A point mutation leads to an unpaired cysteine residue and a molecular weight polymorphism of a functional platelet beta 3 integrin subunit. The Sra alloantigen system of GPIIIa. Santoso S; Kalb R; Kroll H; Walka M; Kiefel V; Mueller-Eckhardt C; Newman PJ J Biol Chem; 1994 Mar; 269(11):8439-44. PubMed ID: 8132570 [TBL] [Abstract][Full Text] [Related]
12. GPIIIa-related PLA1 antigens with different molecular weights: studies in platelets, endothelial cells, and megakaryocytes. Dancis A; Ehmann C; Ferziger R; Grima K; Karpatkin S Blood; 1988 Apr; 71(4):1056-61. PubMed ID: 3355887 [TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody (LK-4) which differentiates PLA1 from PLA2 platelet extracts but not intact platelets. Liu LX; Nardi MA; Flug F; Karpatkin S Thromb Res; 1992 May; 66(4):309-20. PubMed ID: 1384161 [TBL] [Abstract][Full Text] [Related]
14. Expression and purification of functional recombinant epitopes for the platelet antigens, PlA1 and PlA2. Barron-Casella EA; Kickler TS; Rogers OC; Casella JF Blood; 1994 Aug; 84(4):1157-63. PubMed ID: 7519475 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of binding of anti-PLA1 antibodies to platelets with monoclonal antibody LK-4. Evidence for multiple PLA1 receptor sites on platelet GPIIIa. Liu LX; Nardi MA; Casella JF; Karpatkin S Blood; 1996 Nov; 88(9):3601-7. PubMed ID: 8896429 [TBL] [Abstract][Full Text] [Related]
16. Neonatal alloimmune thrombocytopenia due to a new platelet-specific alloantibody. McFarland JG; Blanchette V; Collins J; Newman PJ; Wang R; Aster RH Blood; 1993 Jun; 81(12):3318-23. PubMed ID: 8507868 [TBL] [Abstract][Full Text] [Related]
17. Further characterization of the loop structure of platelet glycoprotein IIIa: partial mapping of functionally significant glycoprotein IIIa epitopes. Kouns WC; Newman PJ; Puckett KJ; Miller AA; Wall CD; Fox CF; Seyer JM; Jennings LK Blood; 1991 Dec; 78(12):3215-23. PubMed ID: 1720699 [TBL] [Abstract][Full Text] [Related]
18. Effect of single amino acid substitutions on the formation of the PlA and Bak alloantigenic epitopes. Goldberger A; Kolodziej M; Poncz M; Bennett JS; Newman PJ Blood; 1991 Aug; 78(3):681-7. PubMed ID: 1713513 [TBL] [Abstract][Full Text] [Related]
19. Assignment of disulphide bonds in human platelet GPIIIa. A disulphide pattern for the beta-subunits of the integrin family. Calvete JJ; Henschen A; González-RodrĂguez J Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):63-71. PubMed ID: 2001252 [TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of platelet surface alloantigens using a monoclonal probe. Janson M; McFarland J; Aster RH Hum Immunol; 1986 Mar; 15(3):251-62. PubMed ID: 3754249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]